Patent 10322029 was granted and assigned to Novartis on June, 2019 by the United States Patent and Trademark Office.
An implant container for containing an ocular implant is described herein. The implant container can releasably couple to an implant delivery device and provide at least partial alignment of the delivery device with an ocular implant during loading of the ocular implant onto the delivery device.